Active 0 6 0 6 O
or 7 9 7 9 O
suspected 10 19 10 19 O
neoplasia 20 29 20 29 B-chronic_disease

Cardiomegaly 0 12 30 42 B-chronic_disease
/ 12 13 42 43 O
valvulopathy 13 25 43 55 B-chronic_disease

Hepatic 0 7 56 63 B-chronic_disease
insufficiency 8 21 64 77 I-chronic_disease

History 0 7 78 85 O
of 8 10 86 88 O
allergy 11 18 89 96 O
to 19 21 97 99 O
IGF-1 22 27 100 105 B-allergy_name

Intracranial 0 12 106 118 B-chronic_disease
hypertension 13 25 119 131 I-chronic_disease

Language 0 8 132 140 B-language_fluency
delay 9 14 141 146 I-language_fluency
( 15 16 147 148 I-language_fluency
lack 16 20 148 152 I-language_fluency
of 21 23 153 155 I-language_fluency
fluent 24 30 156 162 I-language_fluency
phrase 31 37 163 169 I-language_fluency
speech 38 44 170 176 I-language_fluency
) 44 45 176 177 I-language_fluency
reflected 46 55 178 187 O
by 56 58 188 190 O
use 59 62 191 194 O
of 63 65 195 197 O
ADOS 66 70 198 202 O
Module 71 77 203 209 O
1 78 79 210 211 O
or 80 82 212 214 O
2 83 84 215 216 O

Meet 0 4 217 221 O
DSM-5 5 10 222 227 O
criteria 11 19 228 236 O
for 20 23 237 240 O
Autism 24 30 241 247 B-chronic_disease
Spectrum 31 39 248 256 I-chronic_disease
Disorder 40 48 257 265 I-chronic_disease
confirmed 49 58 266 275 O
by 59 61 276 278 O
the 62 65 279 282 O
Autism 66 72 283 289 O
Diagnostic 73 83 290 300 O
Interview 84 93 301 310 O
- 93 94 310 311 O
Revised 94 101 311 318 O
( 102 103 319 320 O
ADI 103 106 320 323 O
- 106 107 323 324 O
R 107 108 324 325 O
) 108 109 325 326 O

Must 0 4 327 331 O
be 5 7 332 334 O
on 8 10 335 337 O
stable 11 17 338 344 O
medication 18 28 345 355 B-treatment
regimens 29 37 356 364 I-treatment
for 38 41 365 368 O
at 42 44 369 371 O
least 45 50 372 377 O
three 51 56 378 383 B-lower_bound
months 57 63 384 390 I-lower_bound
prior 64 69 391 396 I-lower_bound
to 70 72 397 399 O
enrollment 73 83 400 410 O
, 83 84 410 411 O
assuming 85 93 412 420 O
the 94 97 421 424 O
concomitant 98 109 425 436 O
medication 110 120 437 447 O
is 121 123 448 450 O
safe 124 128 451 455 O
for 129 132 456 459 O
use 133 136 460 463 O
with 137 141 464 468 O
IGF-1 142 147 469 474 B-treatment

Patients 0 8 475 483 O
with 9 13 484 488 O
comorbid 14 22 489 497 O
conditions 23 33 498 508 O
deemed 34 40 509 515 O
too 41 44 516 519 O
medically 45 54 520 529 O
compromised 55 66 530 541 O
to 67 69 542 544 O
tolerate 70 78 545 553 O
the 79 82 554 557 O
risk 83 87 558 562 O
of 88 90 563 565 O
experimental 91 103 566 578 O
treatment 104 113 579 588 B-treatment
with 114 118 589 593 I-treatment
IGF-1 119 124 594 599 I-treatment

Renal 0 5 600 605 B-chronic_disease
insufficiency 6 19 606 619 I-chronic_disease

between 0 7 620 627 O
the 8 11 628 631 O
ages 12 16 632 636 B-age
of 17 19 637 639 O
5 20 21 640 641 B-lower_bound
- 21 22 641 642 O
12 22 24 642 644 B-upper_bound
years 25 30 645 650 I-upper_bound
of 31 33 651 653 O
age 34 37 654 657 O

